Italia markets open in 6 hours 59 minutes

Sartorius Aktiengesellschaft (0NIQ.L)

LSE - LSE Prezzo differito. Valuta in EUR.
Aggiungi a portafoglio
544,00+28,21 (+5,47%)
Alla chiusura: 05:45PM GMT

Sartorius Aktiengesellschaft

Otto-Brenner-Strasse 20
Göttingen 37079
Germany
49 551 308 0
http://www.sartorius.com

Settore/i
Settore
Impiegati a tempo pieno12.952

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Dr. Joachim KreuzburgChairman of Exec. Board & CEO1,46MN/D1965
Mr. Rainer LehmannCFO, Member of Exec. Board and Head of Fin., Information Technology & Bus. Process825kN/D1975
Dr. Rene FaberHead of Bioprocess Solutions Division & Member of Exec. Board714kN/D1975
Ms. Petra KirchhoffHead of Corp. Communications & Investor Relations and Member of Supervisory Board56kN/D1969
Mr. John Gerard MackayHead of Lab Products & Services Division and Member of Exec. BoardN/DN/D1962
Mr. Manfred WernerSr. VP of Admin. Organization & AuditingN/DN/DN/D
Ms. Mei WangHead of Production - ChinaN/DN/DN/D
Ms. Patricia SpannagelHead of Quality Assurance - Mechatronics Division GoettingenN/DN/DN/D
Mr. Rashid MaqboolHead of Production & Certification Department - Denver USAN/DN/DN/D
Mr. Manohar KuppusamiHead of Production Department - IndiaN/DN/DN/D
Gli importi risalgono al giorno 31 dicembre 2020 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in EUR.

Descrizione

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.

Governance aziendale

L'ISS Governance QualityScore di Sartorius Aktiengesellschaft al 26 settembre 2021 è 5. I criteri di valutazione fondamentali sono revisione: 6; Consiglio di Amministrazione: 2; diritti degli azionisti: 10; retribuzione: 7.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.